Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Study Finds Testosterone Treatments Boost Sex Drive Of Older Men, But Health Concerns Remain July 7, 2016 Irvin Jackson Add Your Comments New research suggests that older men who undergo testosterone replacement therapy do experience an increase in sexual desire and activity, but the findings come amid continuing concerns about the heart risks linked to testosterone drugs and whether the medications are already overused among men without any true medical need for the treatment. Testosterone replacement therapy, which includes blockbuster drugs like Androgel, Testim, Axiron and others, was initially expected to be a niche treatment for men suffering from testosterone deficiency caused by a medical condition, known as hypogonadism. Amid aggressive marketing by the drug makers, which have promoted use of the “low T” drugs for life style reasons, such as drops in energy, strength or sex drive that are commonly seen among men as they age, the industry has grown to generate more than $2 billion in sales annually in recent years. Learn More About Testosterone Lawsuits Testosterone Gel, Patches, Injections or other Treatments May Cause Heart Attacks, Strokes, Wrongful Death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Testosterone Lawsuits Testosterone Gel, Patches, Injections or other Treatments May Cause Heart Attacks, Strokes, Wrongful Death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In a study published last week in the Journal of Clinical Endocrinology & Metabolism, researchers from Baylor College in Texas report that increasing testosterone levels among older men does result in an increased libido, supporting the advertising claims made by drug makers. The research was funded by AbbVie, which manufactures and sells the blockbuster testosterone gel AndroGel, and the findings do not address the side effects of testosterone drugs, which have recently caused federal regulators to warn that the drugs should only be prescribed to men with a true medical need. Testosterone Gel Benefits In this new study, researchers conducted a placebo-controlled clinical trial involving 470 men ages 65 and older with low libido and low testosterone levels. Some were given a placebo and others were given a testosterone gel treatment, like AndroGel. The findings indicate that the men given actual testosterone reported significant improvements in 10 of the 12 measures of sexual activity that the researchers investigated. They did not report improvements in cases of erectile dysfunction, however. “Our findings indicate low testosterone is one cause contributing to reduced libido and erectile dysfunction in older men,” lead author, Dr. Glenn R. Cunningham, of Baylor College of Medicine and Baylor St. Luke’s Medical Center, said in an Endocrine Society press release. “Men experiencing these symptoms should be evaluated for testosterone deficiency.” The study raises additional questions that the findings may be used to further promote the use of Androgel and other testosterone drug among men without a true medical need, potentially exposing men to serious health risks in an effort to reverse natural symptoms associated with aging. Testosterone Drug Health Risks Last year, the FDA required AbbVie and other drug makers to add new warnings about the potential risk of heart attacks and strokes from testosterone replacement therapy, urging doctors to only prescribe the drugs to men diagnosed with hypogonadism backed up by laboratory testing. The recommendations came after an FDA advisory panel met in September 2014 and reviewed concerns about the link between testosterone therapy and heart risks, and evaluated the widespread overuse of the drugs. Several studies published since late 2013 have highlighted potential cardiovascular risks men may face from testosterone replacement therapy, including findings that suggest some men may be more prone to suffer a heart attack, stroke, blood clots or die. Just weeks before this latest study was released by the Endocrine Society, other researchers warned that men may face a higher risk of heart problems from testosterone even after short-term use. That research was published in the medical journal The Lancet in May, indicating that men who were only given testosterone for a short period of time faced an increased risk of both heart problems and death, noting that those short-term uses are often associated with “lifestyle” uses of the drug by men who do not truly suffer from a medically diagnosed testosterone deficiency. In the press release announcing the recent findings about the benefits of testosterone replacement therapy, the Endocrine Society did warn that the drugs should only be used by men with symptoms of androgen deficiency and low levels of testosterone. “The study was designed to investigate the effectiveness of testosterone therapy,” The Endocrine Society stated. ” It was not large enough or long enough to address issues related to cardiovascular events or clinical prostate cancer.” Testosterone Litigation Following decades of aggressive marketing without providing warnings about the potential health risks, Abbvie and other drug makers now face thousands of Androgel lawsuits, Axiron lawsuits, Testim lawsuits and other testosterone treatment lawsuits over the failure to adequately warn consumers and the medical community. Given the similar allegations raised in the lawsuits, more than 5,000 cases filed throughout the federal court system have been consolidated for pretrial proceedings as part of a multidistrict litigation (MDL), which is centralized before U.S. District Judge Matthew Kennelly in the Northern District of Illinois. As part of the coordinated proceedings, a series of Androgel trials are expected to begin between April and November 2017, which are designed to help the parties gauge how juries may respond to certain evidence and testimony that is likely to be repeated throughout the litigation. If testosterone drug settlements are not reached following bellwether trials in the MDL, the drug makers may face hundreds of individual trial dates in U.S. District Courts nationwide over failure to warn about the heart risks associated with their medications. Tags: AndroGel, Erectile Dysfunction, Heart Attack, Testosterone, Testosterone Gel Image Credit: | More Testosterone Lawsuit Stories Link Between Testosterone Drugs and Heart Risks Not Found in New Study June 19, 2023 Study’s Findings Question Link Between Testosterone Drugs and Blood Clots October 26, 2021 New Testosterone Guidelines Warn Against Unnecessary Use, Prefer Shots Over Transdermal Products January 10, 2020 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (Posted: today) A federal judge wants lawyers involved in hair relaxer lawsuits to provide an update this week on the status of discovery proceedings for a pool of cases being considered for bellwether trial dates. MORE ABOUT: HAIR RELAXER LAWSUITFormaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)Lawyers Selected 32 Hair Relaxer Lawsuits for Bellwether Discovery in MDL (05/13/2025)Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (04/29/2025) Covidien Parietex Optimized Composite (PCOx) Hernia Mesh Lawsuits To Be Prepared for Trial (Posted: today) Two Covidien Parietex Optimized Composite hernia mesh lawsuits have been chosen to be prepared to potentially serve as the third Covidien hernia mesh bellwether trial. MORE ABOUT: HERNIA MESH LAWSUITSecond Bellwether Trial in Covidien Hernia Mesh Lawsuit MDL Set for July 2026 (05/14/2025)Covidien Mesh Lawsuit Set For Trial in Feb. 2026, Over Defective Hernia Implant (04/10/2025)New Bard Hernia Mesh Lawsuits Continue To Be Filed Following Global Settlement (04/03/2025) Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (Posted: yesterday) Six women have filed a joint, multiplaintiff BioZorb tissue marker lawsuit, all indicating that they suffered injuries and complications due to the recalled device’s defective design. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025)Four Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)
New Testosterone Guidelines Warn Against Unnecessary Use, Prefer Shots Over Transdermal Products January 10, 2020
Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (Posted: today) A federal judge wants lawyers involved in hair relaxer lawsuits to provide an update this week on the status of discovery proceedings for a pool of cases being considered for bellwether trial dates. MORE ABOUT: HAIR RELAXER LAWSUITFormaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)Lawyers Selected 32 Hair Relaxer Lawsuits for Bellwether Discovery in MDL (05/13/2025)Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (04/29/2025)
Covidien Parietex Optimized Composite (PCOx) Hernia Mesh Lawsuits To Be Prepared for Trial (Posted: today) Two Covidien Parietex Optimized Composite hernia mesh lawsuits have been chosen to be prepared to potentially serve as the third Covidien hernia mesh bellwether trial. MORE ABOUT: HERNIA MESH LAWSUITSecond Bellwether Trial in Covidien Hernia Mesh Lawsuit MDL Set for July 2026 (05/14/2025)Covidien Mesh Lawsuit Set For Trial in Feb. 2026, Over Defective Hernia Implant (04/10/2025)New Bard Hernia Mesh Lawsuits Continue To Be Filed Following Global Settlement (04/03/2025)
Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (Posted: yesterday) Six women have filed a joint, multiplaintiff BioZorb tissue marker lawsuit, all indicating that they suffered injuries and complications due to the recalled device’s defective design. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025)Four Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)